Yahoo Web Search

Search results

    • Genmab: Growth Is Still a Better Choice

      Genmab: Growth Is Still a Better Choice

      GuruFocus.com via Yahoo Finance· 2 weeks ago

      Genmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developing medicines to treat patients with cancer, multiple ...